Prime Medicine, Inc.
USD3.21
-0.19 (-5.59%)
CEO
Allan Reine
IPO Date
2022-10-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.37
Prev. Close
$3.40
Day Low
$3.06
Day High
$3.37
52W Low
$1.20
52W High
$6.94
Market Cap
$0.58B
Volume
3.31M
| 0 |
| $0.00 |
| 27 Feb 2026 | Reine Allan | director, officer: Chief Executive Officer | A-Award | Acquired | 1,300,000 | $4.38 |
| 24 Feb 2026 | LEE ANN L. | Chief Technical Officer | A-Award | Acquired | 375,000 | $3.34 |
| 24 Feb 2026 | Alenson Carman | See Remarks | A-Award | Acquired | 140,000 | $3.34 |
| 5 Aug 2025 | GV 2021 GP, L.L.C. | 10 percent owner | P-Purchase | Acquired | 1,500,000 | $3.30 |
| 5 Aug 2025 | Alenson Carman | See Remarks | A-Award | Acquired | 6,254 | $4.04 |
| 5 Aug 2025 | Alenson Carman | See Remarks | D-Return | Disposed | 90,498 | $8.49 |
| 5 Aug 2025 | LEE ANN L. | Chief Technical Officer | D-Return | Disposed | 180,995 | $8.49 |
| 5 Aug 2025 | LEE ANN L. | Chief Technical Officer | D-Return | Disposed | 180,995 | $12.30 |